Legal & General Group PLC 23and Me Holding Co. Transaction History

Legal & General Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.4 - $0.91 $29,149 - $66,315	-72,874 Reduced 33.11%	147,233 $78,000
Q4 2023 Feb 15, 2024	BUY	$0.71 - $0.97 $2,450 - $3,348	3,452 Added 1.59%	220,107 $200,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $2.01 $2,114 - $4,428	-2,203 Reduced 1.01%	216,655 $212,000
Q2 2023 Aug 14, 2023	BUY	$1.59 - $2.29 $170,236 - $245,183	107,067 Added 95.77%	218,858 $383,000
Q1 2023 May 15, 2023	BUY	$2.05 - $2.87 $39,394 - $55,152	19,217 Added 20.76%	111,791 $254,000
Q4 2022 Feb 14, 2023	BUY	$2.06 - $3.47 $6,101 - $10,278	2,962 Added 3.31%	92,574 $199,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $88,098 - $173,486	33,884 Added 60.8%	89,612 $256,000
Q2 2022 Aug 22, 2022	BUY	$2.19 - $3.98 $74,236 - $134,914	33,898 Added 155.28%	55,728 $138,000
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $23,786 - $51,634	7,252 Added 49.75%	21,830 $84,000
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $95,485 - $193,158	14,578 New	14,578 $97,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.